MSK physician shares kidney cancer research at annual ASCO GU Symposium
(Memorial Sloan Kettering Cancer Center) Memorial Sloan Kettering's Robert Motzer presented positive data from a phase III randomized study that assessed two different treatment combinations as first-line therapies that may benefit people with advanced kidney cancer.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | International Medicine & Public Health | Kidney Cancer | Study | Urology & Nephrology